β-内酰胺类抗生素致肺部重症感染患者神经系统不良反应的临床研究
Neurological Adverse Reactions in Patients with Severe Pulmonary Infection Caused by β-Lactam Antibiotics
摘要: 目的:探究β-内酰胺类抗生素致肺部重症感染患者神经系统不良反应的临床特点,以此提高防治水平。方法:回顾性分析2015年2月至2016年2月我院确诊的尿毒症并发肺部重症感染42例使用β-内酰胺类抗生素患者的临床资料,分析β-内酰胺类抗生素的品种、剂量及神经系统不良反应的临床特征。结果:尿毒症并发肺部重症感染患者使用β-内酰胺类抗生素行抗感染治疗时易引发神经系统不良反应。神经系统不良反应表现多样,主要为兴奋多语、胡言乱语、神志恍惚、烦躁不安、嗜睡、反应迟钝、失眠及双上肢不自主震颤。患者停药或行血液灌流联合血液透析治疗后,神经系统不良反应均能基本完全消失,且无神经系统后遗症。结论:β-内酰胺类抗生素致尿毒症并发肺部重症感染患者神经系统不良反应较为常见,当患者出现神经系统不良反应时,及时停药,给予合适的治疗方案,不良反应症状能在短期内消失,且不会造成神经系统后遗症。
Abstract: Objective: To investigate the clinical features of neurological adverse reactions in patients with severe pulmonary infection caused by β-lactam antibiotics, so as to improve the control level. Me-thods: The clinical data of 42 patients with uremia complicated with severe pulmonary infection who were diagnosed in the hospital during the period from February 2015 to February 2016 and used β-lactam antibiotics were retrospectively analyzed. The variety and dosage of β-lactam anti-biotics and clinical features of neurological adverse reactions were analyzed. Results: Patients with uremia complicated with severe pulmonary infection were prone to having neurological adverse reactions during anti-infection treatment with β-lactam antibiotics. The neurological adverse reactions mainly included excitation and logomania, babble, trance, dysphoria, lethargy, slow response, insomnia and involuntary tremors of upper limbs. They almost completely disappeared after drug withdrawal or hemoperfusion and hemodialysis, without neurological sequelae. Conclusion: Neurological adverse reactions are common in patients with uremia complicated with severe pulmonary infection caused by β-lactam antibiotics. When patients have neurological ad-verse reactions, they should stop taking drugs and undergo appropriate treatment. The adverse reactions can disappear in a short term, without causing neurological sequelae.
文章引用:陈卫, 杨丽, 华丽. β-内酰胺类抗生素致肺部重症感染患者神经系统不良反应的临床研究[J]. 护理学, 2019, 8(3): 216-221. https://doi.org/10.12677/NS.2019.83041

参考文献

[1] 韦秀芳, 阮素莲, 谢兴文. 慢性肾功能衰竭行维持血液透析患者死亡原因及其影响因素分析[J]. 实用临床医药杂志, 2016, 20(3): 160-161.
[2] 付群英, 王颖, 雷蕾. 尿毒症患者并发肺部感染高危因素分析及预防研究[J]. 河北医学, 2016, 22(3): 394-397.
[3] 杨政, 唐志红, 沈红, 等. 尿毒症患者肺部感染抗菌药物治疗分析[J]. 中华医院感染学杂志, 2015(5): 1059-1061.
[4] 刘艳波, 周龙洋, 吕礼安. 慢性肾功能衰竭患者使用第三代头孢菌素致中枢神经系统不良反应病例分析[J]. 实用药物与临床, 2015, 18(2): 202-205.
[5] Bhattacharyya, S., Darby, R. and Berkowitz, A.L. (2014) Antibiotic-Induced Neuro-toxicity. Current Infectious Disease Reports, 16, 448-453. [Google Scholar] [CrossRef] [PubMed]
[6] Zhang, J., Huang, C., Li, H., et al. (2013) Antibiotic-Induced Neurotoxicity in Dialysis Patients: A Retrospective Study. Renal Failure, 35, 901-910. [Google Scholar] [CrossRef
[7] 王海燕. 肾脏病学[M]. 第3版. 北京: 人民卫生出版社, 2008: 206.
[8] Qin, H.Y., Jia, P. and Liu, H. (2016) Nursing Strategies for Patients with Chronic Renal Failure Undergoing Maintenance Hemodialysis Treatment by Arteriovenous Fistula. Iranian Journal of Public Health, 45, 1270-1275.
[9] 吉勤, 张春艳, 王清. 孟如教授治疗慢性肾衰竭临床经验[J]. 中国中西医结合肾病杂志, 2013, 14(1): 475-476.
[10] 赵先锋. 中医药治疗慢性肾衰竭研究进展[J]. 现代中西医结合杂志, 2014, 23(2): 217-220.
[11] 丛军, 高弼虎. 维持性血液透析对尿毒症患者氧化应激及免疫功能的影响[J]. 中华实用诊断与治疗杂志, 2013, 27(3): 209-211.
[12] Minami, Y., Kajimoto, K., Sato, N., et al. (2016) End-Stage Renal Disease Patients on Chronic Maintenance Hemodialysis in a Hospitalized Acute Heart Failure Cohort: Prevalence, Clinical Characteristics, Therapeutic Options, and Mortality. International Journal of Cardiology, 224, 267-270. [Google Scholar] [CrossRef] [PubMed]
[13] Mor, A., Thomsen, R.W., Ulrichsen, S.P., et al. (2013) Chronic Heart Failure and Risk of Hospitalization with Pneumonia: A Population-Based Study. European Journal of Internal Medicine, 24, 349-353. [Google Scholar] [CrossRef] [PubMed]
[14] 叶红英, 应俊, 方和敬, 等. 慢性肾衰竭维持性血液透析患者肺部感染的危险因素分析[J]. 中华全科医学, 2018, 16(6): 932-934.
[15] 徐泽奇, 徐泽宇. 抗革兰阴性细菌感染抗生素的研发新进展[J]. 药学学报, 2013, 48(7): 993-1004.
[16] 司书毅. 新抗生素与抗菌药物研发专栏[J]. 药学学报, 2018, 53(6): I0003.
[17] 薛晶, 贾燕花, 李进, 等. 头孢曲松钠的亚晶型分类及对产品质量的影响[J]. 药学学报, 2014, 49(7): 1034-1038.
[18] Sugimoto, M., Uchida, I.T., Yamazaki, S., et al. (2003) Evidence for the Involvement of GABA(A) Receptor Blockade in Convulsions Induced by Cephalosporins. Neuropharmacology, 45, 304-314. [Google Scholar] [CrossRef
[19] 杨志忠, 毛健, 段荣, 等. β-内酰胺类抗生素致尿毒症患者神经系统不良反应[J]. 实用药物与临床, 2012, 15(9): 593-594.